Nisa Investment Advisors’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-4,974
Closed -$296 2366
2021
Q3
$296 Buy
4,974
+1,776
+56% +$105K ﹤0.01% 1282
2021
Q2
$218 Sell
3,198
-1,850
-37% -$121K ﹤0.01% 1372
2021
Q1
$350 Hold
5,048
﹤0.01% 1275
2020
Q4
$388K Buy
5,048
+3,036
+151% +$228K ﹤0.01% 1245
2020
Q3
$150K Sell
2,012
-1,092
-35% -$72.8K ﹤0.01% 1408
2020
Q2
$195K Buy
3,104
+582
+23% +$32K ﹤0.01% 1283
2020
Q1
$106K Buy
2,522
+110
+5% +$5.04K ﹤0.01% 1363
2019
Q4
$110K Hold
2,412
﹤0.01% 1426
2019
Q3
$110K Buy
2,412
+2,072
+609% +$116K ﹤0.01% 1438
2019
Q2
$20K Hold
340
﹤0.01% 1607
2019
Q1
$15K Sell
340
-150
-31% -$6.88K ﹤0.01% 1665
2018
Q4
$19K Hold
490
﹤0.01% 1534
2018
Q3
$23K Hold
490
﹤0.01% 1537
2018
Q2
$21K Buy
490
+240
+96% +$10.3K ﹤0.01% 1537
2018
Q1
$10K Buy
+250
New +$9.72K ﹤0.01% 1671

Other funds holding ARNA

Nisa Investment Advisors's ARNA Position: Q4 2021 in Review

Nisa Investment Advisors sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2021, closing a stake of 4,974 shares — an estimated $296 sold.

Nisa Investment Advisors first reported a position in ARNA in Q1 2018 and held it in 15 quarters. The position peaked at $388K in Q4 2020. 316 funds tracked by Wall St. Rank hold ARNA as of Q4 2021.

  • Nisa Investment Advisors reported no remaining Arena Pharmaceuticals Inc position as of Q4 2021 after selling out during the quarter.
  • Nisa Investment Advisors sold 4,974 Arena Pharmaceuticals Inc shares in Q4 2021, an estimated $296.
  • Nisa Investment Advisors first reported a position in Arena Pharmaceuticals Inc in Q1 2018 and held it in 15 quarters.
  • Nisa Investment Advisors's Arena Pharmaceuticals Inc position peaked at $388K in Q4 2020.
  • 316 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2021.

Based on Nisa Investment Advisors's 13F filing for Q4 2021, filed 3 Feb 2022.